| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Traws Pharma, Inc. | Director | Stock Option (Right to Purchase) | 164,000 | 16 Sep 2024 | Direct | ||
| Brooklyn ImmunoTherapeutics, Inc. | Director | Stock Option | 67,000 | 08 Dec 2021 | Direct | ||
| IN8BIO, INC. | Director | Stock Option (right to buy) | 63,150 | 08 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| INAB | IN8BIO, INC. | 08 May 2025 | 1 | $0 | 4 | Director | 12 May 2025, 16:15 |
| INAB | IN8BIO, INC. | 19 Dec 2024 | 1 | $0 | 4 | Director | 23 Dec 2024, 16:15 |
| TRAW | Traws Pharma, Inc. | 16 Sep 2024 | 1 | $0 | 4 | Director | 17 Sep 2024, 17:12 |
| TRAW | Traws Pharma, Inc. | 16 Sep 2024 | 0 | $0 | 3 | Director | 17 Sep 2024, 17:11 |
| INAB | IN8BIO, INC. | 12 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 17:00 |
| INAB | IN8BIO, INC. | 15 Jun 2023 | 1 | $0 | 4 | Director | 16 Jun 2023, 19:44 |
| INAB | IN8BIO, INC. | 16 Aug 2022 | 1 | +$999 | 4 | Director | 18 Aug 2022, 16:09 |
| INAB | IN8BIO, INC. | 01 Jun 2022 | 1 | $0 | 4/A | Director | 23 Sep 2022, 17:07 |
| ERNA | Brooklyn ImmunoTherapeutics, Inc. | 08 Dec 2021 | 1 | $0 | 4 | Director | 10 Dec 2021, 20:00 |
| INAB | IN8BIO, INC. | 29 Jul 2021 | 1 | $0 | 4 | Director | 02 Aug 2021, 21:28 |
| INAB | IN8BIO, INC. | 29 Jul 2021 | 0 | $0 | 3 | Director | 29 Jul 2021, 21:38 |